Clinical Trials on LGMDR23 - LAMA2 Related

Total 51407 results

Butler Hospital

Completed

Interactive Voice Response (IVR) for Methadone Patients

Opioid-Related Disorders

United States
Denver Health and Hospital Authority
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics

Alcohol Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase IV - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VI - 7

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Opioid-Related Disorders

United States
Yih-Ing Hser
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Not yet recruiting

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) (RXR)

Substance-Related Disorders | Opioid-Related Disorders | Narcotic-Related Disorders

United States
West Virginia University
National Institute on Drug Abuse (NIDA)

Recruiting

Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

Opioid-Related Disorders

United States
University of Pennsylvania
Yale University

Recruiting

Tau PET Imaging in Opioid Use Disorder

Opioid-Related Disorders

United States
Geisinger Clinic

Completed

Evaluation of a Medication Disposal Program in Primary Care

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 3

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Fetal Neurobehavioral Development in Methadone Maintained Pregnancies

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Feasibility Study of Take-Home LAAM Medication - 3

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Improving Learning-based Treatment of Cocaine Dependence With Medication

COCAINE-RELATED DISORDERS

United States
National Institute on Drug Abuse (NIDA)

Completed

Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9

Opioid-Related Disorders

United States
University of Pennsylvania

Completed

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Opioid-Related Disorders

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Naltrexone-P1 A-Cocaine

Cocaine-related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Opioid Agonist and Antagonist Effects on Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 3 - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Assessment of Tramadol as a Treatment for Opioid Addiction

Opioid-Related Disorders

United States
Denver Health and Hospital Authority
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing

Alcohol Related Disorders

United States, Canada
US Department of Veterans Affairs

Completed

Effect Of Case Management Following Discharge From Methadone Treatment

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
Indiana University
National Institute on Drug Abuse (NIDA)

Recruiting

Maternal Brain Imaging in Opioid Use Disorder

Substance-Related Disorders | Pregnancy Related | Narcotic-Related Disorders | Substance Use | Opioid Use Disorder | Buprenorphine Dependence

United States
Indivior Inc.

Completed

Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) (OPUS R)

Naloxone | Drug Abuse | Opiate Dependence | Buprenorphine | Opiate-related Disorders
Indivior Inc.

Completed

Open-Label Treatment Extension Study

Opioid Use Disorder | Opioid-related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effect of Clonidine on Responses to Imagery Scripts

Cocaine Abuse | Heroin Abuse

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases

Drug Abuse | Opioid-related Disorders | Narcotic Abuse | Opioid Addiction
Indiana University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder

Substance-Related Disorders | Pregnancy Related | Narcotic-Related Disorders | Opioid Use Disorder | Buprenorphine Dependence | Methadone Dependence

United States
Indivior Inc.

Completed

Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

Opioid Use Disorder | Opioid-related Disorders

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
Kati Järvelä

Completed

A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery

Postoperative Pain | Opioid Related Disorders

Finland
Rennes University Hospital

Terminated

Postoperative and Opioid Free Anesthesia (POFA)

Opioid-Related Disorders | Anesthesia

France
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Recruiting

Substance Abuse Pre-Treatment Screening Study

Alcohol Dependence | Substance Abuse | Cocaine Dependence | Opiate Dependence | Cocaine Abuse

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

Opioid Dependence Treatment Therapies in Pregnancy

Pregnancy | Opioid-Related Disorders

United States

Clinical Trials on LGMDR23 - LAMA2 Related

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations